| 申请日期 | 2025-06-27 | 申请号 | DE102005013221 |
| 公开（公告）号 | DE102005013221A1 | 公开（公告）日 | 2006-09-21 |
| 公开国别 | DE | 申请人省市代码 | 全国 |
| 申请人 | BIOTRONIK VI PATENT AG | ||
| 简介 | Active agent (26) is released in the lumen or tissue of the vessel sections (22, 24, 25) arranged proximally at the blood flow direction of the vessel (10). The catheter (18) as an implant is arranged about 0.5 cm to the nearest stent (16). The magnesium alloy comprises yttrium (3.7-5.5 wt%), rare earth compound (1.5-4.4 wt%) and remainder (greater than 1 wt%). An independent claim is included for method for treating expanded obliterative illnesses of a container. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
